A major output of the project will be the definition of a conceptual framework of PF&S, the implementation of which will identify a specific "nosographical entity" for healthcare professionals, research activities, pharmaceutical industry, regulators, and policy-makers.
The SPRINTT results will thus have relevant clinical and public health implications, filling an important gap in knowledge for practicing evidence-based geriatric medicine. The ultimate goals of SPRINTT are to offer efficient treatment options to physically frail, sarcopenic older persons and to increase their quality of life.
This will directly support the long-term sustainability and efficiency of health- and social-care systems.
A major output of the project will be the definition of a conceptual framework of PF&S, the implementation of which will identify a specific "nosographical entity" for healthcare professionals, research activities, pharmaceutical industry, regulators, and policy-makers.
The SPRINTT results will thus have relevant clinical and public health implications, filling an important gap in knowledge for practicing evidence-based geriatric medicine. The ultimate goals of SPRINTT are to offer efficient treatment options to physically frail, sarcopenic older persons and to increase their quality of life. This will directly support the long-term sustainability and efficiency of health- and social-care systems.